查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760494

2025年全球乳癌篩檢市場報告

Breast Cancer Screening Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年乳癌篩檢市場規模將強勁成長，2029年將達到34.6億美元，年複合成長率（CAGR）為8.3%。預測期內的預期成長與乳癌篩檢率上升、政府措施加強、醫療保健支出增加、行動篩檢單位擴張以及女性人口成長有關。預計這段時期的主要趨勢包括診斷影像技術的進步、非侵入性篩檢技術的興起、基因檢測的進步、基因組檢測的創新以及行動篩檢解決方案的開發。

乳癌發生率的上升預計將推動乳癌篩檢檢測市場的成長。乳癌是指乳腺組織細胞異常且不受控制地增殖，這些細胞可能發展成腫瘤並轉移到身體其他部位。乳癌患者的增加是由於全球人口老化，因為患病風險隨著年齡的成長而顯著增加。乳癌篩檢檢測對於及早發現乳癌、改善治療效果和降低死亡率至關重要。例如，2025 年 3 月，美國非營利組織 Breastcancer.org 預測，2025 年將有約 316,950 名女性被診斷出患有侵襲性乳癌，同時有 59,080 例導管原位癌 (DCIS)。此外，2024 年 12 月，加拿大公共衛生署報告稱，2022 年加拿大預計將有 28,600 名女性被診斷出患有乳癌，導致 5,500 人死亡。因此，乳癌盛行率的上升促進了乳癌篩檢測試市場的擴張。

乳癌篩檢領域的主要企業正優先開發行動篩檢設備等尖端解決方案，以提高可近性、提高早期發現率，並將服務擴展到醫療資源匱乏和偏遠地區。這些行動裝置配備了乳房X光攝影等影像技術，旨在為醫療資源匱乏的地區提供現場乳癌篩檢。例如，2024 年 9 月，印度製藥公司 Granules India Ltd. 推出了「乳房健康快車」（Breast Health Express），以在醫療資源匱乏的地區推廣乳癌篩檢。該設備配備先進的乳房X光攝影和超音波系統，可在移動中提供高品質的篩檢。該舉措旨在為農村和服務匱乏的地區提供早期檢測服務，幫助這些地區的女性獲得關鍵的醫療保健服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球乳癌篩檢測試的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球乳癌篩檢測試市場：成長率分析
  • 全球乳癌篩檢檢測市場表現：規模與成長，2019-2024
  • 全球乳癌篩檢市場預測：規模與成長，2024-2029，2034
  • 全球乳癌篩檢檢測總目標市場（TAM）

第6章市場區隔

  • 全球乳癌篩檢檢測市場（依診斷檢測類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 血液標記檢測
  • 影像檢查
  • 基因檢測
  • 免疫組織化學
  • 全球乳癌篩檢檢測市場風險等級、表現及預測（2019-2024、2024-2029、2034）
  • 高危險群
  • 中度風險族群
  • 平均風險族群
  • 全球乳癌篩檢檢測市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 癌症研究所
  • 實驗室
  • 全球乳癌篩檢檢測市場：血液標記檢測細分（按類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 循環性腫瘤細胞（CTCS）檢測
  • 基因表現測試
  • 循環腫瘤DNA（CTDNA）檢測
  • 蛋白質體生物標記檢測
  • 全球乳癌篩檢檢測市場：影像檢查細分（按類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 乳房X光檢查
  • 磁振造影篩檢測試
  • 分子乳房攝影
  • 正子斷層掃描
  • 超音波
  • 全球乳癌篩檢檢測市場：基因檢測細分（按類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 螢光原位雜合反應
  • HER基因檢測
  • 全球乳癌篩檢檢測市場：免疫組織化學（IHC）檢測細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 雌激素受體 (ER) 測試
  • Ki-67增殖標記檢測
  • 孕酮受體（Pr）測試
  • Her2 或 Neu 偵測

第7章 區域和國家分析

  • 全球乳癌篩檢市場各地區、表現及預測（2019-2024、2024-2029、2034 ）
  • 全球乳癌篩檢市場（依國家/地區篩檢）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 乳癌篩檢檢測市場：競爭格局
  • 乳癌篩檢市場：公司篩檢
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Quest Diagnostics Incorporated
  • Hologic Inc.
  • Hitachi High-Tech Corporation
  • Exact Sciences Corporation
  • Natera Inc.
  • Myriad Genetics Inc.
  • Canon Medical Systems Corporation
  • Provista Diagnostics Inc.
  • POC Medical Systems Inc.
  • Niramai Health Analytix Pvt. Ltd.
  • Kheiron Medical Technologies Limited
  • UE LifeSciences Inc.
  • Dxcover Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年乳癌篩檢市場：提供新機會的篩檢
  • 2029年乳癌篩檢檢測市場：細分領域帶來新機會
  • 2029篩檢乳癌市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r35371

A breast cancer screening test is a medical procedure or diagnostic method designed to detect breast cancer at an early stage, often before any symptoms develop. The main objective of screening is to discover cancer when it is most treatable, thereby potentially lowering mortality rates and enhancing patient outcomes. Early diagnosis through breast cancer screening enables timely treatment and leads to a more favorable prognosis.

The primary types of diagnostic tests used in breast cancer screening include blood marker tests, imaging tests, genetic tests, and immunohistochemistry tests. Blood marker tests identify and quantify specific substances in the blood to support disease detection, monitoring, or risk evaluation. Different levels of risk-high-risk, moderate-risk, and average-risk populations-are considered, and the tests are utilized by various end users, including hospitals, diagnostic centers, cancer institutes, and research laboratories.

The breast cancer screening tests market research report is one of a series of new reports from The Business Research Company that provides breast cancer screening tests market statistics, including the breast cancer screening tests industry's global market size, regional shares, competitors with the breast cancer screening tests market share, detailed breast cancer screening tests market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer screening tests market. This breast cancer screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The breast cancer screening test market size has grown strongly in recent years. It will grow from $2.31 billion in 2024 to $2.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be credited to enhanced reimbursement policies, a stronger emphasis on preventive healthcare, increased health awareness, greater investment in research and development, and heightened awareness regarding early detection.

The breast cancer screening test market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be linked to the rising incidence of breast cancer, increased government initiatives, growing healthcare spending, the expansion of mobile screening units, and a rise in the female population. Key trends expected during this period include technological advancements in imaging, the emergence of non-invasive screening techniques, progress in genetic testing, innovations in genomic testing, and the development of mobile screening solutions.

The increasing incidence of breast cancer is anticipated to drive the growth of the breast cancer screening test market. Breast cancer involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop into a tumor and potentially spread to other body parts. The rise in breast cancer cases is attributed to the aging global population, as older age significantly raises the risk of developing the disease, and longer life expectancies mean a greater number of individuals are at risk. Screening tests for breast cancer are essential for identifying the disease in its early stages, thereby improving treatment outcomes and lowering mortality rates. For example, in March 2025, Breastcancer.org, a nonprofit organization based in the US, projected that approximately 316,950 women would be diagnosed with invasive breast cancer in 2025, along with 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Additionally, in December 2024, the Public Health Agency of Canada reported that an estimated 28,600 women in Canada were expected to be diagnosed with breast cancer in 2022, with 5,500 fatalities anticipated. As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast cancer screening test market.

Leading companies in the breast cancer screening test sector are prioritizing the development of cutting-edge solutions such as mobile screening units to improve accessibility, increase early detection, and extend services to underserved or remote regions. These mobile units are transportable facilities equipped with diagnostic imaging technologies like mammography, designed to deliver on-site breast cancer screening in areas lacking adequate healthcare access. For instance, in September 2024, Granules India Ltd., a pharmaceutical company based in India, introduced the Breast Health Express to promote breast cancer screening in disadvantaged communities. Outfitted with advanced mammography and ultrasound systems, the unit facilitates quality screenings while on the move. This initiative aims to bring early detection services to rural and underserved areas, helping to ensure access to critical healthcare for women in these regions.

In August 2024, Hitachi High-Tech Corporation, a Japan-based producer of electronic and electrical equipment, entered into a strategic alliance with Gencurix Inc. for an undisclosed amount. Through this collaboration, Hitachi seeks to utilize its knowledge in in vitro diagnostics and digital technologies to create accurate and efficient molecular diagnostics for cancer. Gencurix Inc., headquartered in South Korea, specializes in breast cancer testing solutions.

Major players in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., POC Medical Systems Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., Dxcover Limited.

North America was the largest region in the breast cancer screening test market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in breast cancer screening test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the breast cancer screening test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The breast cancer screening test market consists of revenues earned by entities by providing services such as early detection, risk assessment, and tumor detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast cancer screening test market also consists of sales of products including ultrasound equipment, screening software, and breast self-examination kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Cancer Screening Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on breast cancer screening test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast cancer screening test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The breast cancer screening test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Test Type: Blood Marker Test; Imaging Test; Genetic Test; Immunohistochemistry Test
  • 2) By Risk Level: High-risk Population; Moderate-risk Population; Average-risk Population
  • 3) By End User: Hospitals; Diagnostic Centres; Cancer Institutes; Research Laboratories

Subsegments

  • 1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test; Gene Expression Profiling Test; Circulating Tumor Dna (Ctdna) Test; Proteomic Biomarker Test
  • 2) By Imaging Test: Mammography; Magnetic Resonance Imaging Screening Test; Molecular Breast Imaging Test; Positron Emission Tomograph Scan; Ultrasound
  • 3) By Genetic Test: Fluorescence In Situ Hybridization; Her Gene Test
  • 4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test; Ki-67 Proliferation Marker Test; Progesterone Receptor (Pr) Test; Her2 Or Neu Test
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; Fujifilm Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Breast Cancer Screening Test Market Characteristics

3. Breast Cancer Screening Test Market Trends And Strategies

4. Breast Cancer Screening Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Breast Cancer Screening Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Breast Cancer Screening Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Breast Cancer Screening Test Market Growth Rate Analysis
  • 5.4. Global Breast Cancer Screening Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Breast Cancer Screening Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Breast Cancer Screening Test Total Addressable Market (TAM)

6. Breast Cancer Screening Test Market Segmentation

  • 6.1. Global Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Marker Test
  • Imaging Test
  • Genetic Test
  • Immunohistochemistry Test
  • 6.2. Global Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-risk Population
  • Moderate-risk Population
  • Average-risk Population
  • 6.3. Global Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centres
  • Cancer Institutes
  • Research Laboratories
  • 6.4. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Blood Marker Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Circulating Tumor Cells (Ctcs) Test
  • Gene Expression Profiling Test
  • Circulating Tumor Dna (Ctdna) Test
  • Proteomic Biomarker Test
  • 6.5. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Imaging Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammography
  • Magnetic Resonance Imaging Screening Test
  • Molecular Breast Imaging Test
  • Positron Emission Tomograph Scan
  • Ultrasound
  • 6.6. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Genetic Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescence In Situ Hybridization
  • Her Gene Test
  • 6.7. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Immunohistochemistry (Ihc) Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Estrogen Receptor (Er) Test
  • Ki-67 Proliferation Marker Test
  • Progesterone Receptor (Pr) Test
  • Her2 Or Neu Test

7. Breast Cancer Screening Test Market Regional And Country Analysis

  • 7.1. Global Breast Cancer Screening Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Breast Cancer Screening Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Breast Cancer Screening Test Market

  • 8.1. Asia-Pacific Breast Cancer Screening Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Breast Cancer Screening Test Market

  • 9.1. China Breast Cancer Screening Test Market Overview
  • 9.2. China Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Breast Cancer Screening Test Market

  • 10.1. India Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Breast Cancer Screening Test Market

  • 11.1. Japan Breast Cancer Screening Test Market Overview
  • 11.2. Japan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Breast Cancer Screening Test Market

  • 12.1. Australia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Breast Cancer Screening Test Market

  • 13.1. Indonesia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Breast Cancer Screening Test Market

  • 14.1. South Korea Breast Cancer Screening Test Market Overview
  • 14.2. South Korea Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Breast Cancer Screening Test Market

  • 15.1. Western Europe Breast Cancer Screening Test Market Overview
  • 15.2. Western Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Breast Cancer Screening Test Market

  • 16.1. UK Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Breast Cancer Screening Test Market

  • 17.1. Germany Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Breast Cancer Screening Test Market

  • 18.1. France Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Breast Cancer Screening Test Market

  • 19.1. Italy Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Breast Cancer Screening Test Market

  • 20.1. Spain Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Breast Cancer Screening Test Market

  • 21.1. Eastern Europe Breast Cancer Screening Test Market Overview
  • 21.2. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Breast Cancer Screening Test Market

  • 22.1. Russia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Breast Cancer Screening Test Market

  • 23.1. North America Breast Cancer Screening Test Market Overview
  • 23.2. North America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Breast Cancer Screening Test Market

  • 24.1. USA Breast Cancer Screening Test Market Overview
  • 24.2. USA Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Breast Cancer Screening Test Market

  • 25.1. Canada Breast Cancer Screening Test Market Overview
  • 25.2. Canada Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Breast Cancer Screening Test Market

  • 26.1. South America Breast Cancer Screening Test Market Overview
  • 26.2. South America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Breast Cancer Screening Test Market

  • 27.1. Brazil Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Breast Cancer Screening Test Market

  • 28.1. Middle East Breast Cancer Screening Test Market Overview
  • 28.2. Middle East Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Breast Cancer Screening Test Market

  • 29.1. Africa Breast Cancer Screening Test Market Overview
  • 29.2. Africa Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Breast Cancer Screening Test Market Competitive Landscape And Company Profiles

  • 30.1. Breast Cancer Screening Test Market Competitive Landscape
  • 30.2. Breast Cancer Screening Test Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Breast Cancer Screening Test Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips NV
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Hologic Inc.
  • 31.5. Hitachi High-Tech Corporation
  • 31.6. Exact Sciences Corporation
  • 31.7. Natera Inc.
  • 31.8. Myriad Genetics Inc.
  • 31.9. Canon Medical Systems Corporation
  • 31.10. Provista Diagnostics Inc.
  • 31.11. POC Medical Systems Inc.
  • 31.12. Niramai Health Analytix Pvt. Ltd.
  • 31.13. Kheiron Medical Technologies Limited
  • 31.14. UE LifeSciences Inc.
  • 31.15. Dxcover Limited

32. Global Breast Cancer Screening Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Breast Cancer Screening Test Market

34. Recent Developments In The Breast Cancer Screening Test Market

35. Breast Cancer Screening Test Market High Potential Countries, Segments and Strategies

  • 35.1 Breast Cancer Screening Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Breast Cancer Screening Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Breast Cancer Screening Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer